The tumor ablation market size is estimated to be USD 1,350 million in 2022 and is expected to witness a CAGR of 14.53% during the forecast period 2023-2033. The aging populations, increasing innovations in technology for ablation devices, rising demand for minimally invasive treatments among surgeons and patients due to the advantages of quick recovery, patient comfort, and shorter recovery times, and increasing number of hospitals, surgical facilities, and ablation facilities and increase in the number of cancer patients are factors contributing to the market growth. However, the current healthcare reform program in the U.S, and cost containment strategies by respective governments’ are expected to hinder the growth.

Segmentation

By Application

Based on application, the market is segregated into kidney cancer, bone metastasis, lung cancer, liver cancer, prostate cancer, and others. In 2022, the liver cancer segment held the highest market share owing to the increasing prevalence of primary liver cancer and bile duct cancer.

By Technology

On the basis of technology, the market is categorized into microwave ablation, cryoablation, radiofrequency (RF) ablation, irreversible electroporation ablation, and other technologies. In 2022, the microwave ablation segment held the highest market share due to the increasing use of microwave tumor ablation among medical practitioners to treat different cancers, rising private investment in the development of new microwave ablation products, and its superior effectiveness over alternative ablation techniques

By Mode of Treatment

Based on mode of treatment, the market is divided into laparoscopic ablation, surgical ablation, and percutaneous ablation. In 2022, the surgical ablation segment held the highest market share owing to increasing consumer understanding of the advantages of surgical ablation in emerging areas, the widespread use of minimally invasive surgery to treat different tumors in developed markets and expanding patient population for prevalent malignancies such kidney, prostate, liver, and lung.

Regional Markets

In 2022, North America region accounted for the highest revenue in the tumor ablation market and is expected to maintain its dominance during the forecast period. This is attributed to an increase in cancer incidence, government funding for high-quality medical treatment, and the accessibility of reimbursements. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing existence of large healthcare providers in fast-rising economies such as India and China creating new chances for expansion, increasing the number of patients, and rising with government support for the utilization of healthcare in Asia Pacific region.

Competitor Insights

Some of the key players operating in the tumor ablation market are Angiodynamics (Covidien), AngioDynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), EDAP TMS S.A. (France), Ethicon, Inc. (US), Galil Medical, Inc. (U.S.), HealthTronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical (Denmark), Misonix Inc. (US), and Theraclion (France).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including application, technology, and mode of treatment from 2023 to 2033.

Report Scope:

Segmentation: Tumor Ablation Market Report 2022 – 2033

Application (Revenue, USD Million), 2022 – 2033

• Kidney Cancer
• Bone Metastasis
• Lung Cancer
• Liver Cancer
• Prostate Cancer
• Others

Technology (Revenue, USD Million), 2022 – 2033

• Microwave Ablation
• Cryoablation
• Radiofrequency (RF) Ablation
• Irreversible Electroporation Ablation
• Other Technologies

Mode of Treatment (Revenue, USD Million), 2022 – 2033

• Laparoscopic Ablation
• Surgical Ablation
• Percutaneous Ablation

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA